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Abstract. It is widely accepted that the immune system undergoes age-related
changes correlating with increased disease in the elderly. T cell subsets have been
implicated. The aim of this work is firstly to implement and validate a simulation
of T regulatory cell (Treg) dynamics throughout the lifetime, based on a model by
Baltcheva. We show that our initial simulation produces an inversion between
precursor and mature Treys at around 20 years of age, though the output differs
significantly from the original laboratory dataset. Secondly, this report discusses
development of the model to incorporate new data from a cross-sectional study of
healthy blood donors addressing balance between Treys and Th17 cells with novel
markers for Treg. The potential for simulation to add insight into immune aging is
discussed.
1 Introduction to System Dynamics Modelling of Immunity
Simulation has been defined as methods and applications mimicking the behaviour of
a real system [1]. The benefits of simulation to immunology include time- and cost-
effectiveness as well as less labour- and resource-intensiveness resulting from
removal from the biological environment. In vitro experimentation is useful for
investigating individual interactions but is far removed from the whole picture, and in
vivo experimentation is useful for the whole picture but is unlikely to answer specific
questions [2]. Using simulation, flexibility is available for systematically generating
hypotheses and conducting experiments impossible to do practically, yet informed by
robust data and literature.
System dynamics simulations are useful for looking at complex systems over time.
They are characterised by stocks of an entity and flows between stocks [3]. Immune
system examples of stocks include precursor and mature T cell pools and flows might
represent transition of cells from precursor to mature. This technique is useful for
modelling relationships defined by differential equations. An example of a differential
equation describing T cell dynamics is the change in number of precursor cells
equated to proliferation of precursors minus death and maturation rates. This ongoing
work will apply system dynamics simulation technique to complement in vitro studies
of Th 17s and Treg s throughout the lifetime.
2 The Need for Balance: Th 17s and Treys Throughout the Lifetime
The immune system maintains a balance between mounting an adequate immune re-
sponse to protect from infection and restricting the size of the immune response to
2prevent damage to self. There is evidence to suggest an age-related tendency to a pro-
inflammatory environment [4] contributing to more collateral damage and autoimmune
diseases. This work addresses the hypothesis that important contributors to this state of
imbalance are Th17 cells (amplifying immune responses) and Tregs (dampening down
immune responses). Although some studies have shown an age-related increase in the
number of Tregs in human peripheral blood [5][6], it has also been shown that
homeostasis is maintained [7]. One study concluded upon the oscillatory nature of Treg
numbers through life, with peaks in adolescence and in over 60 year olds [8]. A recent
study in Th17 cells with age showed a small decrease in the frequency of Th17 cells in
the CD4+ memory population in elderly donors relative to young [9]. However, for the
balance between Tregs and Th17 cells, there is currently no published literature.
There is evidence that the balance between Tregs and Th 17s is altered in age-
related diseases such as acute coronary syndrome [10]. Thus it is intuitive that this
balance should be examined with a cross sectional study in healthy donors of different
ages. Laboratory experimentation will begin by using flow cytometry to enumerate
peripheral blood cells expressing CD4, CD25 and signature transcription factors of
these subsets: Foxp3 and Helios for Tregs and RORC for Th17 cells.
3 Method: Simulation of Treg Dynamics
Ultimately we wish to build a model of the dynamics of Tregs and Th17 cells throughout
life from data currently being collected. Preliminary work for this has involved building
a system dynamics simulation in AnyLogic 6.5.0 University Edition, based on a
mathematical model by Baltcheva [11]. This model was selected as it comprehensively
incorporates the functional dynamics of Tregs in terms of homeostasis and during an
acute immune response. It characterises the changing precursor and mature Treg
populations throughout the human lifetime. Key assumptions include that there is no
change in function or responsiveness throughout the lifetime, nor a change to other
influential factors on their dynamics such as dendritic cell number and function [11].
Also, the immune response considered includes an expansion and contraction phase, and
only one response can occur at a given timepoint [11]. The original model was based on
numbers of CD4+CD25±CD45R0— (precursor) and CD4+CD25±CD45R0+ (mature)
populations in 119 peripheral blood samples of donors aged 19 to 81 [11]. Although
total numbers of CD4+CD25+ cells remained constant, the ratio of precursor to mature
was inverted in early adulthood. This represents an important dimension to the observed
homeostasis in Treg numbers throughout the lifespan, especially when considering
thymic involution from adolescence, reducing the number of new cells entering the
system.
Ordinary differential equations describe the dynamics of the above mentioned cells,
and stochastic processes control the frequency, duration and antigen-specific nature of
primary and secondary immune responses on the different cell compartments [11]. In
this work, a simple scenario was chosen in order to test the hypothesis that the model
could be implemented in AnyLogic. The scenario assumes a lack of antigen-induced
proliferation and death of both precursor and mature Tregs, no density-dependent pro-
liferation and death and thymic output as the only external input into the various Treg
3subsets [11]. The parameter values used correspond to means of the distributions for
scenario 2iiia given in Baltcheva's work [11]. The simulation is shown below:
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Figure 1: Main View. Events are shown with for time in days (t) and years (y). Flow
variables given by [z] involve a rate of conversion multiplied by the number of cells in the
stocks named Y cloneP, —R and —Q. P corresponds to precursors, R to active matures
and Q to quiescent matures. These stocks are prefixed by Y clone as they represent total
and antigen-specific Tregs determined by an array. Homeostatic parameters apply to the
total Treg population, whereas immune response parameters are applied to a proportion
given by piN. For example, flow of specific precursors into the active mature stock is
given by specific precursor stock multiplied by the maturation rate. Each time point,
AnyLogic recalculates each stock using the flows defined.
An additional class (immuneResponse) controls the immune system functional status
using IRstatechart:
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Figure 2: immuneResponse View. At the beginning of a run the immune system is in the
N °Response state. Every 100.95 time steps, the immune system mounts a primary
immune response with probability qt or defaults to a secondary response. Primaryl and
Secondaryl, represent the expansion phase. PrimaryI I and SecondaryI I, represent the
contraction phase which continues until a new response is instigated. During Primaryl,
parameter b is applied. During Primaryll, b is set to zero and parame-
4ters c, dR and dQ are applied. In Secondary) parameters b and f are applied and in
SecondaryI I these are set to zero and c, dR and dQ are applied.
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Figure 3 (generated using MATLAB 122010a): Output data from AnyLogic over a
complete run. a) Total precursor and quiescent mature Trey stocks. b) Total active
Tregs. Each peak corresponds to antigen-specific clones experiencing either primary
or secondary immune responses.
Figure 4 shows simulation output compared to the original dataset. Data has been col-
lected for each stock over 3 complete replications. The maximum standard deviation
between three runs for the total precursors was 2.753x10-7. The maximum standard
deviation for total quiescent matures was 9411.
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Figure 4: Output data compared to Baltcheva's dataset. a) The proportion of total
Tregs in the precursor stock. b) The proportion of total Tregs in the quiescent stock.
In order to quantify how similar the simulation output was to the laboratory data, both
datasets were split into 10-year age groups. The median was calculated for these
groups, and the difference between medians for simulation output data and laboratory
data have been documented below. A Mann Whitney test was then performed for the
null hypothesis of no difference between laboratory and output data and the p values
are given below:
5Age (Years) Median Difference Mann Whitney Test
Proportion of
Precursors
Proportion of
Matures
Proportion of
Precursors
Proportion of
Matures
10-19 0.3101 0.0207 p=0.083 p=0.658
20-29 0.0525 0.1092 p<0.001 p<0.001
30-39 0.0290 0.1227 p=0.034 p<0.001
40-49 0.0690 0.1182 p=0.001 p<0.001
50-59 0.0587 0.1007 p<0.001 p<0.001
60-69 0.0072 0.1230 p=0.127 p<0.001
70-79 0.0011 0.1204 p=0.808 p<0.001
80-89 0.0805 0.0775 p=0.014 p=0.014
Table 1: Comparison of median output and laboratory data for each 10-year age
group.
4 Discussion and Concluding Remarks
The implementation of Baltcheva's model as a system dynamics simulation has been
documented here and compared to experimental evidence. It has been shown that the
simulation mimics the key feature of inversion of precursor and memory cells in early
adulthood. The lack of statistical similarity between simulation output and laboratory data
indicates that further validation of this model is necessary and will involve a comparison
of other scenarios proposed in Baltcheva's work. Ultimately we will develop and validate
a simulation of our novel dataset of Treg and Th17 cells using this sort of approach.
CD4+CD25±Foxp3+ and CD4±Foxp3±Helios+ cell numbers instead of CD4+CD25+ s
for Treg s will also be collected as they are arguably more specific markers [12][13]. In
terms of improving the simulation, alternatives to continually reactivating a single Treg
clone are required, as is simulation of more than one immune stimulus at a time.
Baltcheva discloses various assumptions including no difference in Treg function [11]. It
may be possible to improve this model by considering functional as well as numerical
changes to Treg subsets with age.
A more abstract research question is whether a simplistic model of immunosenes-
cence can lend useful insight into the biological problem. It can be argued that the process
of simulation alone might allow researchers to address assumptions and allow for
systematic generation of hypotheses. Also, hypotheses which are difficult to test in the
laboratory might be testable with a simulation. For example, we might introduce an
intervention to mimic ablative chemotherapy by depleting each stock at a single time
point. Total values of each stock might then be compared for simulation runs with or
without intervention to make hypotheses about Treg recovery. Simulating the dynamics of
Th17 cells in parallel to Treg s may also allow us to make predictions about the main-
tenance of their balance throughout life, would allow for extreme parameter values to be
tested and may indicate a maximum length of time for homeostasis to be maintained.
Our primary hypothesis is that age alters Treg and Th17 cells with consequences for
health in older age and we aim to conduct a cross sectional study to obtain the distribution
of particular changes. We anticipate that a strategy of both laboratory investigation
6and system dynamics simulation as exemplified by Baltcheva's work will be useful to
address relationships between T cell subsets over time. The model might also be developed
to consider new questions about response to interventions and the length of time the
immune system might be able to maintain Treg and Th17 cell homeostasis.
With thanks to Irina Baltcheva for providing her raw data.
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